Global CNS Disorders Drug Market Professional Survey Report 2016
Notes:
Production, means the output of CNS Disorders Drug
Revenue, means the sales value of CNS Disorders Drug
This report studies CNS Disorders Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Production, means the output of CNS Disorders Drug
Revenue, means the sales value of CNS Disorders Drug
This report studies CNS Disorders Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
- Abbott Laboratories
- Allergan, Inc.
- Astellas Pharma, Inc.
- Astrazeneca
- Bayer Ag
- Biogen Idec (Fumapharm Ag)
- Eli Lilly & Co.
- Forest Laboratories, Inc.
- Glaxosmithkline (Gsk)
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis Ag (Novartis Pharmaceuticals)
- Pfizer, Inc.
- Sanofi–Aventis
- Shire Pharmaceuticals Group, Plc
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd
- Watson Pharmaceuticals, Inc
- Psychiatry
- Depression
- Multiple Sclerosis And Parkinson’S
- Epilepsy/Convulsions
- Alzheimer’S
- Adhd And Narcolepsy
- Migraine And Other Cns Disease
- Application 1
- Application 2
- Application 3
- North America
- China
- Europe
- Southeast Asia
- Japan
- India
Global CNS Disorders Drug Market Professional Survey Report 2016
1 INDUSTRY OVERVIEW OF CNS DISORDERS DRUG
1.1 Definition and Specifications of CNS Disorders Drug
1.1.1 Definition of CNS Disorders Drug
1.1.2 Specifications of CNS Disorders Drug
1.2 Classification of CNS Disorders Drug
1.2.1 Psychiatry
1.2.2 Depression
1.2.3 Multiple Sclerosis And Parkinson’S
1.2.4 Epilepsy/Convulsions
1.2.5 Alzheimer’S
1.2.6 Adhd And Narcolepsy
1.2.7 Migraine And Other Cns Disease
1.3 Applications of CNS Disorders Drug
1.3.1 Application
1.3.2 Application
1.3.3 Application
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 MANUFACTURING COST STRUCTURE ANALYSIS OF CNS DISORDERS DRUG
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of CNS Disorders Drug
2.3 Manufacturing Process Analysis of CNS Disorders Drug
2.4 Industry Chain Structure of CNS Disorders Drug
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF CNS DISORDERS DRUG
3.1 Capacity and Commercial Production Date of Global CNS Disorders Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global CNS Disorders Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global CNS Disorders Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global CNS Disorders Drug Major Manufacturers in 2015
4 GLOBAL CNS DISORDERS DRUG OVERALL MARKET OVERVIEW
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global CNS Disorders Drug Capacity and Growth Rate Analysis
4.2.2 2015 CNS Disorders Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global CNS Disorders Drug Sales and Growth Rate Analysis
4.3.2 2015 CNS Disorders Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global CNS Disorders Drug Sales Price
4.4.2 2015 CNS Disorders Drug Sales Price Analysis (Company Segment)
5 CNS DISORDERS DRUG REGIONAL MARKET ANALYSIS
5.1 North America CNS Disorders Drug Market Analysis
5.1.1 North America CNS Disorders Drug Market Overview
5.1.2 North America 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E CNS Disorders Drug Sales Price Analysis
5.1.4 North America 2015 CNS Disorders Drug Market Share Analysis
5.2 China CNS Disorders Drug Market Analysis
5.2.1 China CNS Disorders Drug Market Overview
5.2.2 China 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E CNS Disorders Drug Sales Price Analysis
5.2.4 China 2015 CNS Disorders Drug Market Share Analysis
5.3 Europe CNS Disorders Drug Market Analysis
5.3.1 Europe CNS Disorders Drug Market Overview
5.3.2 Europe 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E CNS Disorders Drug Sales Price Analysis
5.3.4 Europe 2015 CNS Disorders Drug Market Share Analysis
5.4 Southeast Asia CNS Disorders Drug Market Analysis
5.4.1 Southeast Asia CNS Disorders Drug Market Overview
5.4.2 Southeast Asia 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E CNS Disorders Drug Sales Price Analysis
5.4.4 Southeast Asia 2015 CNS Disorders Drug Market Share Analysis
5.5 Japan CNS Disorders Drug Market Analysis
5.5.1 Japan CNS Disorders Drug Market Overview
5.5.2 Japan 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E CNS Disorders Drug Sales Price Analysis
5.5.4 Japan 2015 CNS Disorders Drug Market Share Analysis
5.6 India CNS Disorders Drug Market Analysis
5.6.1 India CNS Disorders Drug Market Overview
5.6.2 India 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E CNS Disorders Drug Sales Price Analysis
5.6.4 India 2015 CNS Disorders Drug Market Share Analysis
6 GLOBAL 2011-2016E CNS DISORDERS DRUG SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2011-2016E CNS Disorders Drug Sales by Type
6.2 Different Types of CNS Disorders Drug Product Interview Price Analysis
6.3 Different Types of CNS Disorders Drug Product Driving Factors Analysis
6.3.1 Psychiatry of CNS Disorders Drug Growth Driving Factor Analysis
6.3.2 Depression of CNS Disorders Drug Growth Driving Factor Analysis
6.3.3 Multiple Sclerosis And Parkinson’S of CNS Disorders Drug Growth Driving Factor Analysis
6.3.4 Epilepsy/Convulsions of CNS Disorders Drug Growth Driving Factor Analysis
6.3.5 Alzheimer’S of CNS Disorders Drug Growth Driving Factor Analysis
6.3.6 Adhd And Narcolepsy of CNS Disorders Drug Growth Driving Factor Analysis
6.3.7 Migraine And Other Cns Disease of CNS Disorders Drug Growth Driving Factor Analysis
7 GLOBAL 2011-2016E CNS DISORDERS DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2011-2016E CNS Disorders Drug Consumption by Application
7.2 Different Application of CNS Disorders Drug Product Interview Price Analysis
7.3 Different Application of CNS Disorders Drug Product Driving Factors Analysis
7.3.1 Application 1 CNS Disorders Drug Growth Driving Factor Analysis
7.3.2 Application 2 CNS Disorders Drug Growth Driving Factor Analysis
7.3.3 Application 3 CNS Disorders Drug Growth Driving Factor Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF CNS DISORDERS DRUG
8.1 Abbott Laboratories
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Abbott Laboratories 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Abbott Laboratories 2015 CNS Disorders Drug Business Region Distribution Analysis
8.2 Allergan, Inc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Allergan, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Allergan, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.3 Astellas Pharma, Inc.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Astellas Pharma, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Astellas Pharma, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.4 Astrazeneca
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Astrazeneca 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Astrazeneca 2015 CNS Disorders Drug Business Region Distribution Analysis
8.5 Bayer Ag
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Bayer Ag 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bayer Ag 2015 CNS Disorders Drug Business Region Distribution Analysis
8.6 Biogen Idec (Fumapharm Ag)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Biogen Idec (Fumapharm Ag) 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Biogen Idec (Fumapharm Ag) 2015 CNS Disorders Drug Business Region Distribution Analysis
8.7 Eli Lilly & Co.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Eli Lilly & Co. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Eli Lilly & Co. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.8 Forest Laboratories, Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Forest Laboratories, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Forest Laboratories, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.9 Glaxosmithkline (Gsk)
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Glaxosmithkline (Gsk) 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Glaxosmithkline (Gsk) 2015 CNS Disorders Drug Business Region Distribution Analysis
8.10 Johnson & Johnson
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Johnson & Johnson 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Johnson & Johnson 2015 CNS Disorders Drug Business Region Distribution Analysis
8.11 Merck & Co., Inc.
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Merck & Co., Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Merck & Co., Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.12 Novartis Ag (Novartis Pharmaceuticals)
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Novartis Ag (Novartis Pharmaceuticals) 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Novartis Ag (Novartis Pharmaceuticals) 2015 CNS Disorders Drug Business Region Distribution Analysis
8.13 Pfizer, Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Pfizer, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Pfizer, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.14 Sanofi–Aventis
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Sanofi–Aventis 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Sanofi–Aventis 2015 CNS Disorders Drug Business Region Distribution Analysis
8.15 Shire Pharmaceuticals Group, Plc
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Shire Pharmaceuticals Group, Plc 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Shire Pharmaceuticals Group, Plc 2015 CNS Disorders Drug Business Region Distribution Analysis
8.16 Takeda Pharmaceutical Company Limited
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Takeda Pharmaceutical Company Limited 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Takeda Pharmaceutical Company Limited 2015 CNS Disorders Drug Business Region Distribution Analysis
8.17 Teva Pharmaceutical Industries Ltd
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Teva Pharmaceutical Industries Ltd 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Teva Pharmaceutical Industries Ltd 2015 CNS Disorders Drug Business Region Distribution Analysis
8.18 Watson Pharmaceuticals, Inc
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Watson Pharmaceuticals, Inc 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Watson Pharmaceuticals, Inc 2015 CNS Disorders Drug Business Region Distribution Analysis
9 DEVELOPMENT TREND OF ANALYSIS OF CNS DISORDERS DRUG MARKET
9.1 Global CNS Disorders Drug Market Trend Analysis
9.1.1 Global 2016-2021 CNS Disorders Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 CNS Disorders Drug Sales Price Forecast
9.2 CNS Disorders Drug Regional Market Trend
9.2.1 North America 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.2 China 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.3 Europe 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.4 Southeast Asia 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.5 Japan 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.6 India 2016-2021 CNS Disorders Drug Consumption Forecast
9.3 CNS Disorders Drug Market Trend (Product Type)
9.4 CNS Disorders Drug Market Trend (Application)
10 CNS DISORDERS DRUG MARKETING TYPE ANALYSIS
10.1 CNS Disorders Drug Regional Marketing Type Analysis
10.2 CNS Disorders Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of CNS Disorders Drug by Regions
10.4 CNS Disorders Drug Supply Chain Analysis
11 CONSUMERS ANALYSIS OF CNS DISORDERS DRUG
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 CONCLUSION OF THE GLOBAL CNS DISORDERS DRUG MARKET PROFESSIONAL SURVEY REPORT 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF CNS DISORDERS DRUG
1.1 Definition and Specifications of CNS Disorders Drug
1.1.1 Definition of CNS Disorders Drug
1.1.2 Specifications of CNS Disorders Drug
1.2 Classification of CNS Disorders Drug
1.2.1 Psychiatry
1.2.2 Depression
1.2.3 Multiple Sclerosis And Parkinson’S
1.2.4 Epilepsy/Convulsions
1.2.5 Alzheimer’S
1.2.6 Adhd And Narcolepsy
1.2.7 Migraine And Other Cns Disease
1.3 Applications of CNS Disorders Drug
1.3.1 Application
1.3.2 Application
1.3.3 Application
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 MANUFACTURING COST STRUCTURE ANALYSIS OF CNS DISORDERS DRUG
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of CNS Disorders Drug
2.3 Manufacturing Process Analysis of CNS Disorders Drug
2.4 Industry Chain Structure of CNS Disorders Drug
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF CNS DISORDERS DRUG
3.1 Capacity and Commercial Production Date of Global CNS Disorders Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global CNS Disorders Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global CNS Disorders Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global CNS Disorders Drug Major Manufacturers in 2015
4 GLOBAL CNS DISORDERS DRUG OVERALL MARKET OVERVIEW
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global CNS Disorders Drug Capacity and Growth Rate Analysis
4.2.2 2015 CNS Disorders Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global CNS Disorders Drug Sales and Growth Rate Analysis
4.3.2 2015 CNS Disorders Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global CNS Disorders Drug Sales Price
4.4.2 2015 CNS Disorders Drug Sales Price Analysis (Company Segment)
5 CNS DISORDERS DRUG REGIONAL MARKET ANALYSIS
5.1 North America CNS Disorders Drug Market Analysis
5.1.1 North America CNS Disorders Drug Market Overview
5.1.2 North America 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E CNS Disorders Drug Sales Price Analysis
5.1.4 North America 2015 CNS Disorders Drug Market Share Analysis
5.2 China CNS Disorders Drug Market Analysis
5.2.1 China CNS Disorders Drug Market Overview
5.2.2 China 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E CNS Disorders Drug Sales Price Analysis
5.2.4 China 2015 CNS Disorders Drug Market Share Analysis
5.3 Europe CNS Disorders Drug Market Analysis
5.3.1 Europe CNS Disorders Drug Market Overview
5.3.2 Europe 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E CNS Disorders Drug Sales Price Analysis
5.3.4 Europe 2015 CNS Disorders Drug Market Share Analysis
5.4 Southeast Asia CNS Disorders Drug Market Analysis
5.4.1 Southeast Asia CNS Disorders Drug Market Overview
5.4.2 Southeast Asia 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E CNS Disorders Drug Sales Price Analysis
5.4.4 Southeast Asia 2015 CNS Disorders Drug Market Share Analysis
5.5 Japan CNS Disorders Drug Market Analysis
5.5.1 Japan CNS Disorders Drug Market Overview
5.5.2 Japan 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E CNS Disorders Drug Sales Price Analysis
5.5.4 Japan 2015 CNS Disorders Drug Market Share Analysis
5.6 India CNS Disorders Drug Market Analysis
5.6.1 India CNS Disorders Drug Market Overview
5.6.2 India 2011-2016E CNS Disorders Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E CNS Disorders Drug Sales Price Analysis
5.6.4 India 2015 CNS Disorders Drug Market Share Analysis
6 GLOBAL 2011-2016E CNS DISORDERS DRUG SEGMENT MARKET ANALYSIS (BY TYPE)
6.1 Global 2011-2016E CNS Disorders Drug Sales by Type
6.2 Different Types of CNS Disorders Drug Product Interview Price Analysis
6.3 Different Types of CNS Disorders Drug Product Driving Factors Analysis
6.3.1 Psychiatry of CNS Disorders Drug Growth Driving Factor Analysis
6.3.2 Depression of CNS Disorders Drug Growth Driving Factor Analysis
6.3.3 Multiple Sclerosis And Parkinson’S of CNS Disorders Drug Growth Driving Factor Analysis
6.3.4 Epilepsy/Convulsions of CNS Disorders Drug Growth Driving Factor Analysis
6.3.5 Alzheimer’S of CNS Disorders Drug Growth Driving Factor Analysis
6.3.6 Adhd And Narcolepsy of CNS Disorders Drug Growth Driving Factor Analysis
6.3.7 Migraine And Other Cns Disease of CNS Disorders Drug Growth Driving Factor Analysis
7 GLOBAL 2011-2016E CNS DISORDERS DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)
7.1 Global 2011-2016E CNS Disorders Drug Consumption by Application
7.2 Different Application of CNS Disorders Drug Product Interview Price Analysis
7.3 Different Application of CNS Disorders Drug Product Driving Factors Analysis
7.3.1 Application 1 CNS Disorders Drug Growth Driving Factor Analysis
7.3.2 Application 2 CNS Disorders Drug Growth Driving Factor Analysis
7.3.3 Application 3 CNS Disorders Drug Growth Driving Factor Analysis
8 MAJOR MANUFACTURERS ANALYSIS OF CNS DISORDERS DRUG
8.1 Abbott Laboratories
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Abbott Laboratories 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Abbott Laboratories 2015 CNS Disorders Drug Business Region Distribution Analysis
8.2 Allergan, Inc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Allergan, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Allergan, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.3 Astellas Pharma, Inc.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Astellas Pharma, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Astellas Pharma, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.4 Astrazeneca
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Astrazeneca 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Astrazeneca 2015 CNS Disorders Drug Business Region Distribution Analysis
8.5 Bayer Ag
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Bayer Ag 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bayer Ag 2015 CNS Disorders Drug Business Region Distribution Analysis
8.6 Biogen Idec (Fumapharm Ag)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Biogen Idec (Fumapharm Ag) 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Biogen Idec (Fumapharm Ag) 2015 CNS Disorders Drug Business Region Distribution Analysis
8.7 Eli Lilly & Co.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Eli Lilly & Co. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Eli Lilly & Co. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.8 Forest Laboratories, Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Forest Laboratories, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Forest Laboratories, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.9 Glaxosmithkline (Gsk)
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Glaxosmithkline (Gsk) 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Glaxosmithkline (Gsk) 2015 CNS Disorders Drug Business Region Distribution Analysis
8.10 Johnson & Johnson
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Johnson & Johnson 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Johnson & Johnson 2015 CNS Disorders Drug Business Region Distribution Analysis
8.11 Merck & Co., Inc.
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Merck & Co., Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Merck & Co., Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.12 Novartis Ag (Novartis Pharmaceuticals)
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Novartis Ag (Novartis Pharmaceuticals) 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Novartis Ag (Novartis Pharmaceuticals) 2015 CNS Disorders Drug Business Region Distribution Analysis
8.13 Pfizer, Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Pfizer, Inc. 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Pfizer, Inc. 2015 CNS Disorders Drug Business Region Distribution Analysis
8.14 Sanofi–Aventis
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Sanofi–Aventis 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Sanofi–Aventis 2015 CNS Disorders Drug Business Region Distribution Analysis
8.15 Shire Pharmaceuticals Group, Plc
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Shire Pharmaceuticals Group, Plc 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Shire Pharmaceuticals Group, Plc 2015 CNS Disorders Drug Business Region Distribution Analysis
8.16 Takeda Pharmaceutical Company Limited
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Takeda Pharmaceutical Company Limited 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Takeda Pharmaceutical Company Limited 2015 CNS Disorders Drug Business Region Distribution Analysis
8.17 Teva Pharmaceutical Industries Ltd
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Teva Pharmaceutical Industries Ltd 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Teva Pharmaceutical Industries Ltd 2015 CNS Disorders Drug Business Region Distribution Analysis
8.18 Watson Pharmaceuticals, Inc
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Watson Pharmaceuticals, Inc 2015 CNS Disorders Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Watson Pharmaceuticals, Inc 2015 CNS Disorders Drug Business Region Distribution Analysis
9 DEVELOPMENT TREND OF ANALYSIS OF CNS DISORDERS DRUG MARKET
9.1 Global CNS Disorders Drug Market Trend Analysis
9.1.1 Global 2016-2021 CNS Disorders Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 CNS Disorders Drug Sales Price Forecast
9.2 CNS Disorders Drug Regional Market Trend
9.2.1 North America 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.2 China 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.3 Europe 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.4 Southeast Asia 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.5 Japan 2016-2021 CNS Disorders Drug Consumption Forecast
9.2.6 India 2016-2021 CNS Disorders Drug Consumption Forecast
9.3 CNS Disorders Drug Market Trend (Product Type)
9.4 CNS Disorders Drug Market Trend (Application)
10 CNS DISORDERS DRUG MARKETING TYPE ANALYSIS
10.1 CNS Disorders Drug Regional Marketing Type Analysis
10.2 CNS Disorders Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of CNS Disorders Drug by Regions
10.4 CNS Disorders Drug Supply Chain Analysis
11 CONSUMERS ANALYSIS OF CNS DISORDERS DRUG
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 CONCLUSION OF THE GLOBAL CNS DISORDERS DRUG MARKET PROFESSIONAL SURVEY REPORT 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Picture of CNS Disorders Drug
Table Product Specifications of CNS Disorders Drug
Table Classification of CNS Disorders Drug
Figure Global Production Market Share of CNS Disorders Drug by Type in 2015
Figure Psychiatry Picture
Table Major Manufacturers of Psychiatry
Figure Depression Picture
Table Major Manufacturers of Depression
Figure Multiple Sclerosis And Parkinson’S Picture
Table Major Manufacturers of Multiple Sclerosis And Parkinson’S
Figure Epilepsy/Convulsions Picture
Table Major Manufacturers of Epilepsy/Convulsions
Figure Alzheimer’S Picture
Table Major Manufacturers of Alzheimer’S
Figure Adhd And Narcolepsy Picture
Table Major Manufacturers of Adhd And Narcolepsy
Figure Migraine And Other Cns Disease Picture
Table Major Manufacturers of Migraine And Other Cns Disease
Table Applications of CNS Disorders Drug
Figure Global Consumption Volume Market Share of CNS Disorders Drug by Application in 2015
Figure Market Share of CNS Disorders Drug by Regions
Figure North America CNS Disorders Drug Market Size (2011-2021)
Figure China CNS Disorders Drug Market Size (2011-2021)
Figure Europe CNS Disorders Drug Market Size (2011-2021)
Figure Southeast Asia CNS Disorders Drug Market Size (2011-2021)
Figure Japan CNS Disorders Drug Market Size (2011-2021)
Figure India CNS Disorders Drug Market Size (2011-2021)
Table CNS Disorders Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of CNS Disorders Drug in 2015
Figure Manufacturing Process Analysis of CNS Disorders Drug
Figure Industry Chain Structure of CNS Disorders Drug
Table Capacity (K Dose) and Commercial Production Date of Global CNS Disorders Drug Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global CNS Disorders Drug Major Manufacturers in 2015
Table R&D Status and Technology Source of Global CNS Disorders Drug Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global CNS Disorders Drug Major Manufacturers in 2015
Table Global Capacity (K Dose), Sales (K Dose), Price (USD/Dose), Cost (USD/Dose), Sales Revenue (M USD) and Gross Margin of CNS Disorders Drug 2011-2016
Figure Global 2011-2016E CNS Disorders Drug Market Size (Volume) and Growth Rate
Figure Global 2011-2016E CNS Disorders Drug Market Size (Value) and Growth Rate
Table 2011-2016E Global CNS Disorders Drug Capacity and Growth Rate
Table 2015 Global CNS Disorders Drug Capacity List (Company Segment)
Table 2011-2016E Global CNS Disorders Drug Sales and Growth Rate
Table 2015 Global CNS Disorders Drug Sales List (Company Segment)
Table 2011-2016E Global CNS Disorders Drug Sales Price
Table 2015 Global CNS Disorders Drug Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure North America 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure North America 2015 CNS Disorders Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure China 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure China 2015 CNS Disorders Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure Europe 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure Europe 2015 CNS Disorders Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure Southeast Asia 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure Southeast Asia 2015 CNS Disorders Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure Japan 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure Japan 2015 CNS Disorders Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure India 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure India 2015 CNS Disorders Drug Sales Market Share
Table Global 2011-2016E CNS Disorders Drug Sales by Type
Table Different Types CNS Disorders Drug Product Interview Price
Table Global 2011-2016E CNS Disorders Drug Sales by Application
Table Different Application CNS Disorders Drug Product Interview Price
Table Abbott Laboratories Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Abbott Laboratories CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Abbott Laboratories 2015 CNS Disorders Drug Business Region Distribution
Table Allergan, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Allergan, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Allergan, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Astellas Pharma, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Astellas Pharma, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Astellas Pharma, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Astrazeneca Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Astrazeneca CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Astrazeneca 2015 CNS Disorders Drug Business Region Distribution
Table Bayer Ag Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Bayer Ag CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Bayer Ag 2015 CNS Disorders Drug Business Region Distribution
Table Biogen Idec (Fumapharm Ag) Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Biogen Idec (Fumapharm Ag) CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Biogen Idec (Fumapharm Ag) 2015 CNS Disorders Drug Business Region Distribution
Table Eli Lilly & Co. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Eli Lilly & Co. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly & Co. 2015 CNS Disorders Drug Business Region Distribution
Table Forest Laboratories, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Forest Laboratories, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Forest Laboratories, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Glaxosmithkline (Gsk) Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Glaxosmithkline (Gsk) CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Glaxosmithkline (Gsk) 2015 CNS Disorders Drug Business Region Distribution
Table Johnson & Johnson Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Johnson & Johnson CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Johnson & Johnson 2015 CNS Disorders Drug Business Region Distribution
Table Merck & Co., Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Merck & Co., Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Merck & Co., Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Novartis Ag (Novartis Pharmaceuticals) Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Novartis Ag (Novartis Pharmaceuticals) CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Novartis Ag (Novartis Pharmaceuticals) 2015 CNS Disorders Drug Business Region Distribution
Table Pfizer, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Pfizer, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Sanofi–Aventis Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Sanofi–Aventis CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi–Aventis 2015 CNS Disorders Drug Business Region Distribution
Table Shire Pharmaceuticals Group, Plc Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Shire Pharmaceuticals Group, Plc CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Shire Pharmaceuticals Group, Plc 2015 CNS Disorders Drug Business Region Distribution
Table Takeda Pharmaceutical Company Limited Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Takeda Pharmaceutical Company Limited CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Takeda Pharmaceutical Company Limited 2015 CNS Disorders Drug Business Region Distribution
Table Teva Pharmaceutical Industries Ltd Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Teva Pharmaceutical Industries Ltd CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Teva Pharmaceutical Industries Ltd 2015 CNS Disorders Drug Business Region Distribution
Table Watson Pharmaceuticals, Inc Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Watson Pharmaceuticals, Inc CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Watson Pharmaceuticals, Inc 2015 CNS Disorders Drug Business Region Distribution
Figure Global 2016-2021 CNS Disorders Drug Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 CNS Disorders Drug Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 CNS Disorders Drug Sales Price (USD/Dose) Forecast
Figure North America 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Dose) of CNS Disorders Drug by Types 2016-2021
Table Global Consumption Volume (K Dose) of CNS Disorders Drug by Applications 2016-2021
Table Traders or Distributors with Contact Information of CNS Disorders Drug by Regions
Table Part of Interviewees Record List
Figure Picture of CNS Disorders Drug
Table Product Specifications of CNS Disorders Drug
Table Classification of CNS Disorders Drug
Figure Global Production Market Share of CNS Disorders Drug by Type in 2015
Figure Psychiatry Picture
Table Major Manufacturers of Psychiatry
Figure Depression Picture
Table Major Manufacturers of Depression
Figure Multiple Sclerosis And Parkinson’S Picture
Table Major Manufacturers of Multiple Sclerosis And Parkinson’S
Figure Epilepsy/Convulsions Picture
Table Major Manufacturers of Epilepsy/Convulsions
Figure Alzheimer’S Picture
Table Major Manufacturers of Alzheimer’S
Figure Adhd And Narcolepsy Picture
Table Major Manufacturers of Adhd And Narcolepsy
Figure Migraine And Other Cns Disease Picture
Table Major Manufacturers of Migraine And Other Cns Disease
Table Applications of CNS Disorders Drug
Figure Global Consumption Volume Market Share of CNS Disorders Drug by Application in 2015
Figure Market Share of CNS Disorders Drug by Regions
Figure North America CNS Disorders Drug Market Size (2011-2021)
Figure China CNS Disorders Drug Market Size (2011-2021)
Figure Europe CNS Disorders Drug Market Size (2011-2021)
Figure Southeast Asia CNS Disorders Drug Market Size (2011-2021)
Figure Japan CNS Disorders Drug Market Size (2011-2021)
Figure India CNS Disorders Drug Market Size (2011-2021)
Table CNS Disorders Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of CNS Disorders Drug in 2015
Figure Manufacturing Process Analysis of CNS Disorders Drug
Figure Industry Chain Structure of CNS Disorders Drug
Table Capacity (K Dose) and Commercial Production Date of Global CNS Disorders Drug Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global CNS Disorders Drug Major Manufacturers in 2015
Table R&D Status and Technology Source of Global CNS Disorders Drug Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global CNS Disorders Drug Major Manufacturers in 2015
Table Global Capacity (K Dose), Sales (K Dose), Price (USD/Dose), Cost (USD/Dose), Sales Revenue (M USD) and Gross Margin of CNS Disorders Drug 2011-2016
Figure Global 2011-2016E CNS Disorders Drug Market Size (Volume) and Growth Rate
Figure Global 2011-2016E CNS Disorders Drug Market Size (Value) and Growth Rate
Table 2011-2016E Global CNS Disorders Drug Capacity and Growth Rate
Table 2015 Global CNS Disorders Drug Capacity List (Company Segment)
Table 2011-2016E Global CNS Disorders Drug Sales and Growth Rate
Table 2015 Global CNS Disorders Drug Sales List (Company Segment)
Table 2011-2016E Global CNS Disorders Drug Sales Price
Table 2015 Global CNS Disorders Drug Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure North America 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure North America 2015 CNS Disorders Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure China 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure China 2015 CNS Disorders Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure Europe 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure Europe 2015 CNS Disorders Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure Southeast Asia 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure Southeast Asia 2015 CNS Disorders Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure Japan 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure Japan 2015 CNS Disorders Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of CNS Disorders Drug 2011-2016 (K Dose)
Figure India 2011-2016E CNS Disorders Drug Sales Price (USD/Dose)
Figure India 2015 CNS Disorders Drug Sales Market Share
Table Global 2011-2016E CNS Disorders Drug Sales by Type
Table Different Types CNS Disorders Drug Product Interview Price
Table Global 2011-2016E CNS Disorders Drug Sales by Application
Table Different Application CNS Disorders Drug Product Interview Price
Table Abbott Laboratories Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Abbott Laboratories CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Abbott Laboratories 2015 CNS Disorders Drug Business Region Distribution
Table Allergan, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Allergan, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Allergan, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Astellas Pharma, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Astellas Pharma, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Astellas Pharma, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Astrazeneca Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Astrazeneca CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Astrazeneca 2015 CNS Disorders Drug Business Region Distribution
Table Bayer Ag Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Bayer Ag CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Bayer Ag 2015 CNS Disorders Drug Business Region Distribution
Table Biogen Idec (Fumapharm Ag) Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Biogen Idec (Fumapharm Ag) CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Biogen Idec (Fumapharm Ag) 2015 CNS Disorders Drug Business Region Distribution
Table Eli Lilly & Co. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Eli Lilly & Co. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly & Co. 2015 CNS Disorders Drug Business Region Distribution
Table Forest Laboratories, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Forest Laboratories, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Forest Laboratories, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Glaxosmithkline (Gsk) Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Glaxosmithkline (Gsk) CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Glaxosmithkline (Gsk) 2015 CNS Disorders Drug Business Region Distribution
Table Johnson & Johnson Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Johnson & Johnson CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Johnson & Johnson 2015 CNS Disorders Drug Business Region Distribution
Table Merck & Co., Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Merck & Co., Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Merck & Co., Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Novartis Ag (Novartis Pharmaceuticals) Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Novartis Ag (Novartis Pharmaceuticals) CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Novartis Ag (Novartis Pharmaceuticals) 2015 CNS Disorders Drug Business Region Distribution
Table Pfizer, Inc. Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Pfizer, Inc. CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer, Inc. 2015 CNS Disorders Drug Business Region Distribution
Table Sanofi–Aventis Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Sanofi–Aventis CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi–Aventis 2015 CNS Disorders Drug Business Region Distribution
Table Shire Pharmaceuticals Group, Plc Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Shire Pharmaceuticals Group, Plc CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Shire Pharmaceuticals Group, Plc 2015 CNS Disorders Drug Business Region Distribution
Table Takeda Pharmaceutical Company Limited Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Takeda Pharmaceutical Company Limited CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Takeda Pharmaceutical Company Limited 2015 CNS Disorders Drug Business Region Distribution
Table Teva Pharmaceutical Industries Ltd Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Teva Pharmaceutical Industries Ltd CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Teva Pharmaceutical Industries Ltd 2015 CNS Disorders Drug Business Region Distribution
Table Watson Pharmaceuticals, Inc Information List
Table Type I CNS Disorders Drug Overview
Table Type II CNS Disorders Drug Overview
Table Type III CNS Disorders Drug Overview
Table 2015 Watson Pharmaceuticals, Inc CNS Disorders Drug Revenue, Sales, Ex-factory Price
Figure 2015 Watson Pharmaceuticals, Inc 2015 CNS Disorders Drug Business Region Distribution
Figure Global 2016-2021 CNS Disorders Drug Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 CNS Disorders Drug Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 CNS Disorders Drug Sales Price (USD/Dose) Forecast
Figure North America 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 CNS Disorders Drug Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Dose) of CNS Disorders Drug by Types 2016-2021
Table Global Consumption Volume (K Dose) of CNS Disorders Drug by Applications 2016-2021
Table Traders or Distributors with Contact Information of CNS Disorders Drug by Regions
Table Part of Interviewees Record List
